PROVIDER PROFILE · NPI 1215345558

Junyue QuO.D.

PRACTICEINNA YASKIN DO PCSee all providers at this practice →

OptometryFreehold, NJI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

997

Unique beneficiaries

—

Total services

1,231

Distinct HCPCS

Medicare payment

$77K

Peer benchmark

Total Medicare services vs. 865 Optometry providers in NJ — top quintile (cohort median 305).

PRESCRIBING · PART D · 2024

Total Rx claims

368

Beneficiaries

—

Total drug cost

$88K

Distinct drugs

Brand share

41.3%

Top prescribed drugs

Latanoprost113 claims

Neomycin/Polymyxin B/Dexametha53 claims

Prednisolone Acetate47 claims

Cyclosporine37 claims

Dorzolamide Hcl/Timolol Maleat28 claims

QUALITY · MIPS · 2024

Final MIPS score

82.8

Quality

88.7

Cost

57.8

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

0.33%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$717

Payment records

By payment type

Food and Beverage$717

REFERRAL NETWORK

Where Junyue Qu's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 3 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	11	13

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
TEMPLE UNIVERSITY HOSPITAL, INC	15	22
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	12	18
Sanjay Kamat Ophthalmology · Cheektowaga, NY	12	19

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history